Suppr超能文献

Sirtuins 家族作为内皮细胞功能障碍的靶点:对血管老化的影响。

Sirtuins family as a target in endothelial cell dysfunction: implications for vascular ageing.

机构信息

Department of Pharmacy, and Zhejiang Provincial Key Laboratory of Ageing and Neurological Disorder Research, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Institute of Primate Research, Nairobi, Kenya.

出版信息

Biogerontology. 2020 Oct;21(5):495-516. doi: 10.1007/s10522-020-09873-z. Epub 2020 Apr 13.

Abstract

The vascular endothelium is a protective barrier between the bloodstream and the vasculature that may be disrupted by different factors such as the presence of diseased states. Diseases like diabetes and obesity pose a great risk toward endothelial cell inflammation and oxidative stress, leading to endothelial cell dysfunction and thereby cardiovascular complications such as atherosclerosis. Sirtuins are NAD-dependent histone deacetylases that are implicated in the pathophysiology of cardiovascular diseases, and they have been identified to be important regulators of endothelial cell function. A handful of recent studies suggest that disbalance in the regulation of endothelial sirtuins, mainly sirtuin 1 (SIRT1), contributes to endothelial cell dysfunction. Herein, we summarize how SIRT1 and other sirtuins may contribute to endothelial cell function and how presence of diseased conditions may alter their expressions to cause endothelial dysfunction. Moreover, we discuss how the beneficial effects of exercise on the endothelium are dependent on SIRT1. These mainly include regulation of signaling pathways related to endothelial nitric oxide synthase phosphorylation and nitric oxide production, mitochondrial biogenesis and mitochondria-mediated apoptotic pathways, oxidative stress and inflammatory pathways. Sirtuins as modulators of the adverse conditions in the endothelium hold a promising therapeutic potential for health conditions related to endothelial dysfunction and vascular ageing.

摘要

血管内皮是血液和血管之间的一道保护屏障,可能会被不同的因素破坏,如疾病状态的存在。糖尿病和肥胖等疾病对内皮细胞炎症和氧化应激构成极大威胁,导致内皮细胞功能障碍,从而引发心血管并发症,如动脉粥样硬化。沉默调节蛋白是一种依赖 NAD 的组蛋白去乙酰化酶,与心血管疾病的病理生理学有关,它们被确定为内皮细胞功能的重要调节剂。一些最近的研究表明,内皮沉默调节蛋白(主要是 SIRT1)调节失衡导致内皮细胞功能障碍。本文总结了 SIRT1 和其他沉默调节蛋白如何有助于内皮细胞功能,以及疾病状态的存在如何改变它们的表达导致内皮功能障碍。此外,我们还讨论了运动对内皮的有益作用是否依赖于 SIRT1。这些作用主要包括调节与内皮型一氧化氮合酶磷酸化和一氧化氮产生、线粒体生物发生和线粒体介导的凋亡途径、氧化应激和炎症途径相关的信号通路。沉默调节蛋白作为内皮不良条件的调节剂,为与内皮功能障碍和血管老化相关的健康状况提供了有希望的治疗潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验